iVIEW Therapeutics will present its novel sustained-release povidone iodine ophthalmic formulation for the treatment of acute conjunctivitis in TechConnect World Innovation Summit & Expo and US National Innovation Summit and National SBIR/STTR Conference

March 6, 2017

Doylestown, Pennsylvania--iVIEW Therapeutics Inc. is pleased to announce Dr. Bo Liang, President will present in 2017’s TechConnect World Innovation Summit & Expo and US National Innovation Summit and National SBIR/STTR Conference, May 15-17, 2017, just outside Washington, D.C., at the Gaylord National Resort & Convention Center, National Harbor, MD. In addition of accepted oral paper presentation scheduled at 11:55am on May 17, iVIEW was accepted to showcase the technology during the conference.

Submission Number: 2145
Technology Title: Development of a Novel in-situ Gel Povidone Iodine Ophthalmic Drop for the Treatment of Viral Conjunctivitis
http://techconnectworld.com/World2017 […]

iVIEW Therapeutics was awarded SBIR Innovative grant by NIH’s National Eye Institute

September 12, 2016

Doylestown, Pennsylvania--iVIEW Therapeutics Inc., an innovative start-up specialty pharmaceutical company focusing on topical drug and medical device development, today announced that it has received a Small Business Innovation Research (SBIR) Award from National Eye Institute(NEI) at National Institutes of Health (NIH). The phase I SBIR grant is awarded to iVIEW's project titled " Novel Extended Release Povidone Iodine Ophthalmic Drop for Viral Conjunctivitis". "This award is a NEI's recognition of iVIEW's innovative approach to solve this unmet medical need -- viral conjunctivitis", Dr. Bo Liang, Founder & Director at iVIEW comments, "we will progress quickly though pre-clinical studies and move into proof-of-concept human trials with the innovative extended release formulation of Povidone Iodine ophthalmic drops for viral conjunctivitis." Dr. John J. Baldwin, Co-founder and Director of iVIEW, further commented, "This work is a further extention of the Founders long term interest in novel treatments for ocular diseases through improving the profile of established medicaments using extended release strategies"[…]

Pennsylvania Biotechnology Center at Bucks County
3805 Old Easton Road
Doylestown PA 18902 USA
Copyright © 2020 iVIEW Therapeutics, Inc. All rights reserved.